Daily non-political popular news in brief.

Disabled hit huge roadblocks in routine health care

People with physical disabilities endure substandard health care and a pervasive sense that they are a burden to doctors, according to a Northwestern University physician who is lead author of a commentary in JAMA. These patients often ram into roadblocks when they try to obtain basic care and life-saving diagnostic tests, reports Kristi Kirschner, M.D. Patients and health care workers have been injured because of inadequate facilities. Kirschner offers an overdue blueprint for change.

Read more »

Keywords: disabled, hit, huge, roadblocks, routine, health, care, roadblock

« Previous | Next »

Similar news on "Disabled hit huge roadblocks in routine health care":

1. RAND study finds women with heart disease and diabetes less likely to receive proper care
   05-14-2007 · EurekAlert!
   Women with heart disease and diabetes are less likely to receive several types of routine outpatient medical care than men who have similar health problems, according to a RAND Corporation study issued today.While previous research has shown that women less frequently receive expensive medical care such as angioplasty for heart disease, few studies have evaluated gender disparities in managed care settings.
   Similar news · Read more »
   
2. Want healthy gums? Hit the dairy aisle
   02-06-2008 · EurekAlert!
   Consumers have long known that including dairy in their diets can help maintain healthy bones and even help promote weight loss. However, a recent study published in the January issue of the Journal of Periodontology, the official publication of the American Academy of Periodontology, demonstrated that routine intake of dairy products may also help promote periodontal health.
   Similar news · Read more »
   
3. Advance in understanding of blood pressure gene could lead to new treatments
   02-04-2007 · EurekAlert!
   Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
   Similar news · Read more »
   
4. Study shows value of HIV screening in virtually all health settings
   12-04-2006 · EurekAlert!
   Voluntary screening for HIV should be a routine part of the medical care of all adults, not just those at high risk, according to a study by researchers at the Yale School of Medicine. The team reports in the December 5 Annals of Internal Medicine that routine HIV screening is cost-effective, even in communities where as few as two in 1,000 people have undiagnosed HIV infection.
   Similar news · Read more »
   
5. Health disparities in prostate cancer stem from lack of care, not lack of knowledge
   03-12-2007 · EurekAlert!
   Decreasing the rates of prostate cancer among black men may require improving access to routine health care, rather than increased education about the disease, a study from the University of North Carolina at Chapel Hill School of Medicine suggests.
   Similar news · Read more »
   
6. Congestive heart failure leads to greater disability, nursing home admissions
   01-07-2008 · EurekAlert!
   A University of Michigan Health System study has found that congestive heart failure patients patients were much more likely to be disabled than people without the condition. They were found to be much more likely to require care from nursing homes and family members.
   Similar news · Read more »
   
7. Improving The Patient Experience One Meal At A Time
   09-29-2006 · ScienceDaily
   Sometimes innovation in health care takes the form of advanced imaging technology or breakthroughs in drug treatments. Sometimes it takes the form of hamburgers cut into squares and soup served in a cup.
   Similar news · Read more »
   
8. Doctor urges health-care workers to be alert to suicide risk amongst cancer patients
   10-18-2006 · EurekAlert!
   A Canadian oncologist has urged doctors and other health-care professionals to be more aware of the potential risk of suicide among cancer patients and to offer extra support to the most vulnerable and their families. Analysis of 1.3 million American cancer patients (online Annals of Oncology Oct. 19) reveals suicide rate two to two and half times that of general population.
   Similar news · Read more »
   
9. Researchers show that veins stiffen as we age
   10-31-2006 · EurekAlert!
   As if creaking joints and hardening of the arteries weren't bad enough, a research team from the University of Delaware and the Christiana Care Health System has now confirmed that even our veins stiffen as we age.And that physiological change may be an important factor in the development of high blood pressure, or hypertension, which currently affects an estimated 65 million Americans, most of them older adults, according to UD researcher William Farquhar.
   Similar news · Read more »
   
10. Antibody reduces incidence of acute rejection in high-risk kidney transplant patients
    11-08-2006 · EurekAlert!
    Nearly 70 percent of kidney transplant patients get short-term drug therapy initially administered during surgery to help prevent rejection. In the first direct comparison of the two drugs most commonly given to ward off acute kidney rejection, an international study led by Washington University School of Medicine in St. Louis shows that one -- anti-thymocyte globulin -- is superior. The results also suggest the drug could potentially save millions of dollars in health care costs.
    Similar news · Read more »